Cannabis Innovations – serie
Visar alla böcker i serien Cannabis Innovations. Handla med fri frakt och snabb leverans.
2 produkter
2 produkter
Häftad, Engelska, 2024
1 085 kr
Skickas inom 5-8 vardagar
Embark on a transformative journey through uncharted realms of research and industry with the first book of the "Cannabis Innovations" series. This multidisciplinary effort breaks the mold of typical cannabis texts by providing chapters written by a diverse array of professionals actively shaping the frontiers of cannabis science and business. Regulatory consultants, lawyers, pharmacologists, industry operators, and academics unite to offer seldom encountered perspectives found in traditional cannabis discourse. Our compilation is a carefully curated exploration of the advanced and interconnected complexities of cannabis and is tailored for those with a foundational understanding, ready to delve deeper into the subject. This is part of a larger DeGruyter initiative which focuses on innovative and novel topics, each volume of this series serves as a guide through the multifaceted landscape of cannabis. Step into a pragmatic view of the cannabis industry’s future, where research and innovation converge to advance our understanding of this complex plant, helping us become poised to balance the risks and benefits for the challenges that lay ahead.
- Nyhet
Häftad, Engelska, 2026
939 kr
Skickas inom 3-6 vardagar
The cannabis industry runs on confident assumptions, not always on evidence. Ideas feel natural simply because they go unexamined. What passes for structure is often an architecture of confidence, improvised in urgency, later mistaken for permanence. In an era of social media manufacturing quasi-magical claims – equally promising salvation or catastrophe – legitimacy itself becomes fragile. The book is organized around Myths, Mysteries, and Truths It examines species classifications shaping markets, patents redefining ownership, narratives of limitless safety, who is called an expert, and why data collection systems fail. It explores cannabinoid chemistry beyond cannabis, the global hemp–marijuana divide, and the afterlife of prohibition in modern policy. For regulators, clinicians, researchers, attorneys, investors, and industry leaders, this volume offers something rare: clarity, proportion, and a disciplined framework for separating evidence from narrative.